We are Owlet Owlet is a leading pediatric health platform and the only company globally to offer U.S. FDA-cleared and internationally medically-certified wearable pediatric monitors for home use.
The business is unprofitable at the operating level (-7.81% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 35.4% YoY with margins expanding 18.1pp.
Negative free cash flow of -$11M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$107M
▲ +35.4% YoY
Net Income (TTM)
-$46M
▼ -216.5% YoY
Op. Margin
-10.35%
▲ +18.1pp YoY
ROIC
-29.82%
▲ +138.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$10M
▲ +1.6% YoY
Op. Cash Flow (TTM)
-$10M
▲ +3.7% YoY
Net Debt
-$17M
Net Cash Position
Cash & Equiv.
$35M
5Y CAGR: +7.0%
Continue Research